Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics of Valacyclovir Oral Solution in Children

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is in the age of 2-12 years.~* Subject has an indication for (val)acyclovir prophylaxis and are planned to receive valacyclovir oral solution.~* Subject is managed with a central venous catheter (CVC/Port-a-Cath).~* Subject's parents have signed the Informed Consent Form prior to screening evaluations.~* Subject is willing to participate after study procedures are explained in comprehensible language for the child.~Exclusion Criteria:~* Severe anemia (\<6.0 mmol/L).~* Full dose has not been taken.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Valacyclovir oral solution (Type: OTHER): Valacyclovir oral solution as administered in standard of care. Dosage: 10 mg/kg BID for children weighing less than 40 kg and 500 mg BID for children weighing 40 kg or more.

Based on this trial design, predict the completion outcome and termination type (if applicable).